GlassScriptPhysician profile
Allison Mary Johns
NPI 1598129918
$1,051.29
in general payments reported to CMS, 2019-2025
17 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.39 · 2023: $492 · 2024: $218 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $275.68 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $118.09 | 2022-2025 | Jardiance, Mounjaro, Trulicity |
| Corcept Therapeutics | $95.08 | 2023-2024 | Korlym |
| Pfizer INC. | $81.14 | 2023-2024 | |
| Insulet Corporation | $65.17 | 2022-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.38 | 2023-2025 | Jardiance |
| Dexcom, INC. | $56.01 | 2023-2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $54.10 | 2023-2024 | Recorlev, Gvoke Hypopen |
| Beta Bionics, INC. | $51.30 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Tandem Diabetes Care, INC. | $46.50 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $31.56 | 2025 | Tepezza |
| Almatica Pharma LLC | $23.92 | 2025 | Teriparatide |
| Sequel Med Tech, LLC | $21.91 | 2025 | Twiist |
| Abbott Laboratories | $21.51 | 2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $18.07 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.51 | 2025 | Minimed 780g |
| Amryt Pharma Holdings LTD | $14.36 | 2023 | Mycapssa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Johns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.